GLP-1 Weight Loss Drugs Linked to Bone Conditions and Gout Risk
Research presented at the American Academy of Orthopedic Surgeons meeting indicates GLP-1 weight loss medications like Ozempic may increase osteoporosis, osteomalacia, and gout risks by up to 30%.


